MDR, IVDR, re-cert ISO 13485

Medi­cal device manu­fac­tu­r­ers to face chal­lenges in 2019 too!

In 2018, an initi­al cour­se was plot­ted by many medi­cal device manu­fac­tu­r­ers on the long road to MDR com­pli­ance. In 2019 it will be important for them to car­ry on reso­lut­e­ly along that road, adap­ting both their own orga­ni­sa­ti­on and their coope­ra­ti­on with deve­lo­p­ment part­ners, sup­pli­ers and dis­tri­bu­tors, and also noti­fied bodies, to the new Euro­pean regu­la­ti­ons in order to achie­ve MDR com­pli­ance. This in spi­te of the fact that many ques­ti­ons thrown up by the MDR and IVDR have still not been resol­ved, in spi­te of the fact that essen­ti­al ins­tances such as the Euda­med data­ba­se – on which manu­fac­tu­r­ers have no influence – are still not func­tio­ning pro­per­ly, and in spi­te of the fact that a con­sidera­ble num­ber of noti­fied bodies have so far not even made an appli­ca­ti­on for accre­di­ta­ti­on under the MDR / IVDR. From that point of view, it is to be hoped that the year 2019 will at least bring cla­ri­ty in some cases.

It’s not as if the chal­lenges refer­red to abo­ve only affect ‘clas­si­cal’ device manu­fac­tu­r­ers. Incre­asing­ly, the pro­ducts them­sel­ves are inter­con­nec­ted with data­ba­ses of health­ca­re pro­fes­sio­nals, pro­vi­ders of main­ten­an­ce ser­vices or pati­ents’ devices, or their appli­ca­ti­on is sup­port­ed by accom­pany­ing apps. Soft­ware may be qua­li­fia­ble and clas­si­fia­ble as a medi­cal device within the mea­ning of the MDR. The requi­re­ments rela­ting to the (cyber-)security of digi­tal pro­ducts should not be underestimated.

Tog­e­ther with the recer­ti­fi­ca­ti­on of their qua­li­ty manage­ment sche­me in accordance with DIN ISO 13485:2016, which must be fina­li­sed in 2019, manu­fac­tu­r­ers – of ana­lo­gue and digi­tal pro­ducts – can only be encou­ra­ged and sup­port­ed in their (con­tin­ued) imple­men­ta­ti­on of the requi­re­ments of the MDR / IVDR rela­ting to qua­li­ty manage­ment. It is important to focus careful­ly here on the con­fi­gu­ra­ti­on of the risk manage­ment sys­tem and the imple­men­ta­ti­on of cli­ni­cal assess­ments and cli­ni­cal tri­als. The aim pur­sued with the MDR / IVDR, that of mini­mi­sing the risks posed by medi­cal devices to pati­ents and users, also demands opti­mi­sed sup­pli­er manage­ment from manu­fac­tu­r­ers, and clo­ser coope­ra­ti­on with dis­tri­bu­tors too. It is a mat­ter of being able to retrace the enti­re life cycle of the pro­duct all the way through into the sup­p­ly chain, from the pro­vi­der of deve­lo­p­ment ser­vices on the one hand to the end user on the other, so that, when all is said and done, strin­gent con­trac­tu­al con­trol of the inter­ac­tion of the eco­no­mic ope­ra­tors is necessary.


Stay up-to-date

We use your email address exclusively for sending our newsletter. You have the right to revoke your consent at any time with effect for the future. For further information, please refer to our privacy policy.